Anders Själander

Professor och överläkare i internmedicin

Biträdande examinator för kunskapsprov för läkare

Vetenskaplig meritering: Docent

Pedagogisk meritering: Excellent lärare

Kontakt

anders.sjalander@umu.se

090-786 53 82

Verksam som

Professor, överläkare vid Institutionen för folkhälsa och klinisk medicin

Byggnad 1A, plan 4, målpunkt B41, Norrlands universitetssjukhus Umeå universitet, 901 85 Umeå

Vägar till svensk legitimation för läkare utbildade i tredje land: [Paths to Swedish medical license for international medical graduates]

Läkartidningen, Sveriges läkarförbund 2025, Vol. 122

Hultin, Magnus; Själander, Anders; Werner, Mimmi; et al.

Early career progression in young adults with coeliac disease: a register‐based retrospective cohort study

Acta Paediatrica

Johansson, Katarina; Norström, Fredrik; Ivarsson, Anneli; et al.

ABO and RhD blood groups as contributors to dyslipidaemia: a cross-sectional study

Lipids in Health and Disease, Vol. 24, (1)

Mickelsson, Malin; Ekblom, Kim; Stefansson, Kristina; et al.

Exploring the extent of post-analytical errors, with a focus on transcription errors - an intervention within the VIPVIZA study

Clinical Chemistry and Laboratory Medicine

Mickelsson, Malin; Ekblom, Kim; Stefansson, Kristina; et al.

Thromboembolic events, major bleeding and mortality in essential thrombocythaemia and polycythaemia vera: a matched nationwide population-based study

British Journal of Haematology, John Wiley & Sons 2024, Vol. 204, (5) : 1740-1751

Enblom-Larsson, Anneli; Renlund, Henrik; Andréasson, Björn; et al.

Improved adherence to statin treatment and differences in results between men and women after pictorial risk communication: a sub-study of the VIPVIZA RCT

European Journal of Clinical Pharmacology, Springer 2024, Vol. 80, (8) : 1209-1218

Holmberg, Henrik; Glader, Eva-Lotta; Näslund, Ulf; et al.

Rätt nivå på kunskapsprovet, men regionerna skulle kunna göra mer

Läkartidningen

Hultin, Magnus; Själander, Anders

Prevalence of atrial fibrillation and reasons for undertreatment with oral anticoagulants

Journal of Thrombosis and Thrombolysis, Springer Nature 2024, Vol. 57 : 101-106

Lilja, Johan; Själander, Anders; Själander, Sara

ABO blood groups, RhD factor and their association with subclinical atherosclerosis assessed by carotid ultrasonography

Journal of Clinical Medicine, MDPI 2024, Vol. 13, (5)

Mickelsson, Malin; Ekblom, Kim; Stefansson, Kristina; et al.

Peri- and postoperative risk for stroke after surgery for lumbar spinal stenosis: a retrospective register study

Brain and Spine, Elsevier 2024, Vol. 4

Wegdell, Gustav Sven Christian; Själander, Anders; Mukka, Sebastian; et al.

Risk factors for major bleeding in patients with atrial fibrillation and CKD G3–G5D on oral anticoagulants

Clinical Kidney Journal, Oxford University Press 2024, Vol. 17, (8)

Welander, Frida; Renlund, Henrik; Själander, Anders

The impact of Covid-19 in patients with chronic myeloid leukemia: a nationwide population-based study

Leukemia, Springer Nature 2023, Vol. 37 : 1156-1159

Dahlén, Torsten; Flygt, Hjalmar; Lübking, Anna; et al.

Erythrocytosis, thrombocytosis, and rate of recurrent thromboembolic event: a population based cohort study

European Journal of Haematology, John Wiley & Sons 2023, Vol. 110, (6) : 608-617

Enblom, Anneli; Andréasson, Björn; Holmberg, Henrik; et al.

Entrustable professional activities (EPAs) for undergraduate medical education: development and exploration of social validity

BMC Medical Education, BioMed Central (BMC) 2023, Vol. 23, (1)

Gummesson, Christina; Alm, Stina; Cederborg, Anna; et al.

Direct oral anticoagulants: patient reported adherence and minor bleedings

Journal of Thrombosis and Thrombolysis, Springer 2023, Vol. 56, (1) : 55-64

Hayat, Amina; Själander, Anders; Wallvik, Jonas

Reduced dose direct oral anticoagulants compared with warfarin with high time in therapeutic range in nonvalvular atrial fibrillation

Journal of Thrombosis and Thrombolysis, Springer Nature 2023, Vol. 55, (3) : 415-425

Jansson, Martin; Själander, Sara; Sjögren, Vilhelm; et al.

Direct oral anticoagulants versus warfarin in patients with non-valvular atrial fibrillation and CKD G3-G5D

Clinical Kidney Journal, Oxford University Press 2023, Vol. 16, (5) : 835-844

Welander, Frida; Renlund, Henrik; Dimény, Emöke; et al.

Adverse outcomes in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors: Follow-up of patients diagnosed 2002–2017 in a complete coverage and nationwide agnostic register study

American Journal of Hematology, John Wiley & Sons 2022, Vol. 97, (4) : 421-430

Dahlén, Torsten; Edgren, Gustaf; Ljungman, Per; et al.

Time to initiation of lipid-lowering drugs for subclinical atherosclerosis: sub-study of VIPVIZA randomized controlled trial, with single-arm cross-over

European Heart Journal Open, Oxford University Press 2022, Vol. 2, (1)

Holmberg, Henrik; Sjölander, Maria; Glader, Eva-Lotta; et al.

Fem år med kunskapsprovet har gett oss 503 kompetenta kollegor

Läkartidningen

Hultin, Magnus; Själander, Anders

Celiac disease and upper secondary school achievement in Sweden: A retrospective cohort study

BMC Pediatrics, BioMed Central (BMC) 2022, Vol. 22, (1)

Johansson, Katarina; Norström, Fredrik; Green, Peter H R; et al.

Incidence and risk factors of venous thromboembolism in men and women

Thrombosis Research, Vol. 214 : 82-86

Lind, Marcus; Johansson, Magdalena; Själander, Anders; et al.

Efficacy and safety of warfarin in patients with non-valvular atrial fibrillation and CKD G3-G5D

Clinical Kidney Journal, Oxford University Press 2022, Vol. 15, (6) : 1169-1178

Welander, Frida; Renlund, Henrik; Dimény, Emöke; et al.

Prevalence of Subclinical Coronary Artery Atherosclerosis in the General Population

Circulation, American Heart Association 2021, Vol. 144, (12) : 916-929

Bergström, Göran; Persson, Margaretha; Adiels, Martin; et al.

Successful tyrosine kinase inhibitor discontinuation outside clinical trials: data from the population-based Swedish chronic myeloid leukaemia registry

British Journal of Haematology, John Wiley & Sons 2021, Vol. 193, (5) : 915-921

Flygt, Hjalmar; Sandin, Fredrik; Dahlén, Torsten; et al.

Molecular status 36 months after TKI discontinuation in CML is highly predictive for subsequent loss of MMR: final report from AFTER-SKI

Leukemia, Springer Nature 2021, Vol. 35, (8) : 2416-2418

Richter, Johan; Lübking, Anna; Söderlund, Stina; et al.

Bleeding risk in patients with venous thromboembolic events treated with new oral anticoagulants

Journal of Thrombosis and Thrombolysis, Springer 2021, Vol. 52, (1) : 315-323

Wange, Niklas; Renlund, Henrik; Själander, Anders

Prophylactic anticoagulants to prevent venous thromboembolism in patients with nephrotic syndrome: A retrospective observational study

PLOS ONE, Public Library of Science (PLoS) 2021, Vol. 16, (7)

Welander, Frida; Holmberg, Henrik; Dimény, Emöke; et al.

Inviting the Test Takers to Challenge the Items Might Drive Quality Improvement in National Licensing Tests for International Medical Graduates

EBMA 2020: Past, Present and Future Assessment in Medical Education

Hultin, Magnus; Edin, Benoni B.; Själander, Anders

Direct comparisons of effectiveness and safety of treatment with Apixaban, Dabigatran and Rivaroxaban in atrial fibrillation

Thrombosis Research, PERGAMON-ELSEVIER SCIENCE LTD 2020, Vol. 185 : 135-141

Jansson, Martin; Själander, Sara; Sjögren, Vilhelm; et al.

Increased Risk of Chronic Myeloid Leukemia Following Gastric Conditions Indicating Helicobacter pylori Infection: A Case-Control Study

Cancer Epidemiology, Biomarkers and Prevention, Philadelphia: American Association of Cancer Research 2020, Vol. 29, (1) : 151-156

Larfors, Gunnar; Richter, Johan; Själander, Anders; et al.

Predictors for INR-control in a well-managed warfarin treatment setting

Journal of Thrombosis and Thrombolysis, Springer 2019, Vol. 47, (2) : 227-232

Björck, Fredrik; Kadhim, Hayder; Själander, Anders

Kunskapsprovet säkrar kompetens och förmåga

Dagens Medicin

Hultin, Magnus; Själander, Anders; Hultberg, Pernilla; et al.

Two Years Experiences of a new Swedish National Proficiency Test for Doctors of Medicine.

undee: 2018

Hultin, Magnus; Edin, Benoni B.; Själander, Anders

Sänkta krav på utländska läkare vore förödande

Dagens Samhälle, (4 dec)

Hultin, Magnus; Själander, Anders; Edin, Benoni; et al.

NOAK vid venös tromboembolism samt hantering av blödningar

Läkartidningen, Sveriges läkarförbund 2018, Vol. 115, (49-50)

Själander, Sara; Själander, Anders

Dabigatran, rivaroxaban and apixaban vs. high TTR warfarin in atrial fibrillation

Thrombosis Research, Elsevier 2018, Vol. 167 : 113-118

Själander, Sara; Sjögren, Vilhelm; Renlund, Henrik; et al.

Atherothrombosis and Thromboembolism: Position Paper from the Second Maastricht Consensus Conference on Thrombosis

Thrombosis and Haemostasis, SCHATTAUER GMBH-VERLAG MEDIZIN NATURWISSENSCHAFTEN 2018, Vol. 118, (2) : 229-250

Spronk, H. M. H.; Padro, T.; Siland, J. E.; et al.

Triple therapy after PCI - Warfarin treatment quality and bleeding risk

PLOS ONE, Public Library Science 2018, Vol. 13, (12)

Wadell, Daniel; Jensen, Jens; Englund, Erling; et al.

Warfarin treatment quality and prognosis in patients with mechanical heart valve prosthesis

Heart, BMJ Publishing Group Ltd 2017, Vol. 103, (3) : 198-203

Grzymala-Lubanski, Bartosz; Svensson, Peter J.; Renlund, Henrik; et al.

Increased proportion of mature NK cells is associated with successful imatinib discontinuation in chronic myeloid leukemia

Leukemia, Vol. 31, (5) : 1108-1116

Ilander, M; Olsson-Strömberg, U; Schlums, H; et al.

The impact of socio-economic factors on treatment choice and mortality in chronic myeloid leukaemia

European Journal of Haematology, Vol. 98, (4) : 398-406

Larfors, Gunnar; Sandin, Fredrik; Richter, Johan; et al.

Ischemic stroke rates decline in patients with atrial fibrillation as anticoagulants uptake improves: A Swedish cohort study

Thrombosis Research, PERGAMON-ELSEVIER SCIENCE LTD 2017, Vol. 158 : 44-48

Mochalina, Natalia; Isma, Nazim; Svensson, Peter J.; et al.

Bleeding complications and mortality in warfarin-treated VTE patients, dependence of INR variability and iTTR

Thrombosis and Haemostasis, Vol. 117, (1) : 27-32

Sandén, Per; Renlund, Henrik; Svensson, Peter J.; et al.

Venous thromboembolism and cancer risk

Journal of Thrombosis and Thrombolysis, Vol. 43, (1) : 68-73

Sandén, Per; Svensson, Peter J; Själander, Anders

Assessment of use vs discontinuation of oral anticoagulation after pulmonary vein isolation in patients with atrial fibrillation

JAMA cardiology, American Medical Association 2017, Vol. 2, (2) : 146-152

Själander, Sara; Holmqvist, Fredrik; Smith, J Gustav; et al.

Non-vitamin K oral anticoagulants are non-inferior for stroke prevention but cause fewer major bleedings than well-managed warfarin: a retrospective register study

PLOS ONE, PUBLIC LIBRARY SCIENCE 2017, Vol. 12, (7)

Sjögren, Vilhelm; Byström, Björn; Renlund, Henrik; et al.

Safety and Efficacy of Bridging With Low-Molecular-Weight Heparin During Temporary Interruptions of Warfarin: A Register-Based Cohort Study

Clinical and applied thrombosis/hemostasis, Sage Publications 2017, Vol. 23, (8) : 961-966

Sjögren, Vilhelm; Grzymala-Lubanski, Bartosz; Renlund, Henrik; et al.

Advanced phase chronic myeloid leukaemia (CML) in the tyrosine kinase inhibitor era: a report from the Swedish CML register

European Journal of Haematology, Vol. 98, (1) : 57-66

Söderlund, Stina; Dahlén, Torsten; Sandin, Fredrik; et al.

Warfarin persistence among atrial fibrillation patients – why is treatment ended?

Cardiovascular Therapeutics, Vol. 34, (6) : 468-474

Björck, Fredrik; Ek, Agnes; Johansson, Lars; et al.

Visa publikationer i DiVA

Forskningsprojekt

29 april 2013 till 31 december 2027

VIPVIZA

Publicerad: 06 maj, 2022

Fler utländska läkare på väg till svensk sjukvård efter prov

Publicerad: 17 dec, 2018

Vill ge varje patient rätt behandling i rätt tid